Erratum to “15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity”

Documenti analoghi

• 15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity
  di: Chen, Kan, et al.
  Pubblicazione: (2014)
• Erratum to “15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity”
  di: Kan Chen, et al.
  Pubblicazione: (2014-01-01)
• 15-Deoxy-∆-12,14-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
  di: Jingjing Li, et al.
  Pubblicazione: (2019-01-01)
• 15-Deoxy-∆-(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
  di: Li, Jingjing, et al.
  Pubblicazione: (2019)
• Rosiglitazone and 15-deoxy-Δ(12,14)-prostaglandin J(2), ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut
  di: Cuzzocrea, Salvatore, et al.
  Pubblicazione: (2003)